Jinling Pharmaceutical Co.,Ltd.’s Net Profit Rose 11% in First Quarter of 2023

Jinling Pharmaceutical Co.,Ltd. (金陵药业股份有限公司) (000919.SZ) reported a net profit of 49.3 million yuan in the first quarter of 2023, up 11% year-on-year.

Meanwhile, the company posted 708.5 million yuan in revenue, up 2.2% year-on-year.

At the end of the reporting period, it had 4.5 billion yuan in total assets and 845.4 million yuan in total liabilities, with a liability-to-asset ratio of 18.7%.